Privia Health to Report Third Quarter 2023 Results on Friday, November 3
11 10월 2023 - 9:30PM
Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it
plans to release financial results for its third quarter and
nine-month periods ended September 30, 2023 before market open on
Friday, November 3, 2023.
The press release is expected to be publicly
disseminated by 7:00 am ET and will also be available on the
Company’s Investor Relations website at ir.priviahealth.com. Privia
Health management will host a conference call beginning at 8:00 am
ET on the same day, Friday, November 3, to discuss the results and
management’s outlook for future financial and operational
performance.
You can visit
ir.priviahealth.com/news-and-events/events-and-presentations to
listen to the call via live webcast. The webcast will be archived
and available for replay for on-demand listening shortly after the
completion of the call under the same link. If you wish to
participate in the live conference call, then please go to
https://register.vevent.com/register/BI93f79e2535cf432ab5d86149b9f61609
to pre-register and obtain your dial-in number and passcode.
About Privia Health
Privia Health™ is a technology-driven, national
physician enablement company that collaborates with medical groups,
health plans, and health systems to optimize physician practices,
improve patient experiences, and reward doctors for delivering
high-value care in both in-person and virtual settings. The Privia
Platform is led by top industry talent and exceptional physician
leadership, and consists of scalable operations and end-to-end,
cloud-based technology that reduces unnecessary healthcare costs,
achieves better outcomes, and improves the health of patients and
the well-being of providers. For more information, visit
priviahealth.com.
ContactRobert BorchertSVP, Investor &
Corporate CommunicationsIR@priviahealth.com817.783.4841
Privia Health (NASDAQ:PRVA)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Privia Health (NASDAQ:PRVA)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024